Company: BIAF
Filing Date: 2025-06-27
Form Type: POS AM
Source: 0001641172-25-016927
Chunk: 76

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-27
Form: POS AM
Chunk 76
---
2024 Offerings, effect a sale of any securities with a party first introduced by the WallachBeth in connection with the August 2024 Offerings, we will pay to WallachBeth the same cash fee and percentage of warrants set forth above upon the completion of such transaction.

Terms of the Warrants

The Inducement Warrants and the August 2024 Common Warrants (collectively, the “August 2024 Investor Warrants”) are exercisable commencing on the effective date of stockholder approval of the issuance of the Inducement Warrant Shares and the August 2024 Common Warrant Shares (collectively, the “August 2024 Investor Warrant Shares”), as applicable, which approval was obtained on October 2, 2024, and will expire on the fifth anniversary of such date. The August 2024 Investor Warrants have an exercise price of $1.50 per share.

If at any time a registration statement registering the issuance of the shares of Common Stock issuable upon exercise of the August 2024 Investor Warrants under the Securities Act is not effective or available, the holder may, in its sole discretion, elect to exercise the Inducement Warrants or August 2024 Investor Warrants, as applicable, through a cashless exercise, in which case the holder would receive upon such exercise the net number of shares of Common Stock determined according to the formula set forth in such warrant.

The exercise price of the August 2024 Investor Warrants, and the number of shares issuable upon exercise of the August 2024 Investor Warrants, is subject to adjustment in the event of any stock dividend or split, reverse stock split, recapitalization, reorganization or similar transaction, as described in the August 2024 Investor Warrants.

A holder does not have the right to exercise any portion of the August 2024 Investor Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% (or, upon election of the holder, 9.99%) of the number of shares of our Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of such warrants. However, any holder may increase or decrease such percentage, provided that any increase will not be effective until the 61st day after such election.

In the event of a Fundamental Transaction (as such term is defined in the August 2024 Investor Warrants), then the successor entity will succeed to